Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?

Bouman CA, den Broeder AA, van der Maas A, van den Hoogen FH, Landewé RB, van Herwaarden N.

RMD Open. 2017 Mar 20;3(1):e000327. doi: 10.1136/rmdopen-2016-000327. eCollection 2017.

2.

Prevalence and clinical significance of lumbosacral transitional vertebra (LSTV) in a young back pain population with suspected axial spondyloarthritis: results of the SPondyloArthritis Caught Early (SPACE) cohort.

de Bruin F, Ter Horst S, Bloem JL, van den Berg R, de Hooge M, van Gaalen F, Dagfinrud H, van Oosterhout M, Landewé R, van der Heijde D, Reijnierse M.

Skeletal Radiol. 2017 May;46(5):633-639. doi: 10.1007/s00256-017-2581-1. Epub 2017 Feb 24.

3.

Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.

Regel A, Sepriano A, Baraliakos X, van der Heijde D, Braun J, Landewé R, Van den Bosch F, Falzon L, Ramiro S.

RMD Open. 2017 Jan 27;3(1):e000397. doi: 10.1136/rmdopen-2016-000397. eCollection 2017.

4.

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.

Sepriano A, Regel A, van der Heijde D, Braun J, Baraliakos X, Landewé R, Van den Bosch F, Falzon L, Ramiro S.

RMD Open. 2017 Jan 27;3(1):e000396. doi: 10.1136/rmdopen-2016-000396. eCollection 2017.

5.
6.
7.

Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort.

Turina MC, Yeremenko N, van Gaalen F, van Oosterhout M, Berg IJ, Ramonda R, Lebre CM, Landewé R, Baeten D.

RMD Open. 2017 Jan 11;3(1):e000319. doi: 10.1136/rmdopen-2016-000319. eCollection 2017.

8.

Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials.

Landewé RB, Connell CA, Bradley JD, Wilkinson B, Gruben D, Strengholt S, van der Heijde D.

Arthritis Res Ther. 2016 Sep 23;18(1):212.

9.

Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.

de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL.

Arthritis Res Ther. 2016 Sep 1;18:196. doi: 10.1186/s13075-016-1093-z.

10.

Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort.

Rubio Vargas R, van den Berg R, van Lunteren M, Ez-Zaitouni Z, Bakker PA, Dagfinrud H, Ramonda R, Landewé R, Molenaar E, van Gaalen FA, van der Heijde D.

RMD Open. 2016 Jun 16;2(1):e000283. doi: 10.1136/rmdopen-2016-000283. eCollection 2016.

11.

Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis.

Burmester GR, Landewé R, Genovese MC, Friedman AW, Pfeifer ND, Varothai NA, Lacerda AP.

Ann Rheum Dis. 2017 Feb;76(2):414-417. doi: 10.1136/annrheumdis-2016-209322. Epub 2016 Jun 23.

12.

When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS).

Gvozdenović E, Allaart CF, van der Heijde D, Ferraccioli G, Smolen JS, Huizinga TW, Landewé R.

RMD Open. 2016 Apr 28;2(1):e000221. doi: 10.1136/rmdopen-2015-000221. eCollection 2016.

13.

Association of the different types of radiographic damage with physical function in patients with rheumatoid arthritis: analysis of the RAPID trials.

Gherghe AM, Ramiro S, Landewé R, Mihai C, van der Heijde D.

RMD Open. 2016 Mar 11;2(1):e000219. doi: 10.1136/rmdopen-2015-000219. eCollection 2016.

14.

Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis.

van der Heijde D, Landewé RB, Mease PJ, McInnes IB, Conaghan PG, Pricop L, Ligozio G, Richards HB, Mpofu S.

Arthritis Rheumatol. 2016 Aug;68(8):1914-21. doi: 10.1002/art.39685.

15.

Social Role Participation Questionnaire for patients with ankylosing spondylitis: translation into Dutch, reliability and construct validity.

van Genderen S, Plasqui G, Lacaille D, Arends S, van Gaalen F, van der Heijde D, Heuft L, Keszei A, Luime J, Spoorenberg A, Landewé R, Gignac M, Boonen A.

RMD Open. 2016 Feb 1;2(1):e000177. doi: 10.1136/rmdopen-2015-000177. eCollection 2016.

16.

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis.

Rudwaleit M, Rosenbaum JT, Landewé R, Marzo-Ortega H, Sieper J, van der Heijde D, Davies O, Bartz H, Hoepken B, Nurminen T, Deodhar A.

Arthritis Care Res (Hoboken). 2016 Jun;68(6):838-44. doi: 10.1002/acr.22848.

17.

DAS steered therapy in clinical practice; cross-sectional results from the METEOR database.

Gvozdenović E, Wolterbeek R, van der Heijde D, Huizinga T, Allaart C, Landewé R.

BMC Musculoskelet Disord. 2016 Jan 16;17:33. doi: 10.1186/s12891-016-0878-1.

18.

Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis.

Bergstra SA, Markusse IM, Akdemir G, Ronday HK, Han KH, Lems WF, Kerstens PJ, van den Berg R, Landewé RB, Allaart CF.

Clin Rheumatol. 2016 Aug;35(8):2101-7. doi: 10.1007/s10067-015-3145-1. Epub 2015 Dec 22.

19.

Signal intensity loss of the intervertebral discs in the cervical spine of young patients on fluid sensitive sequences.

de Bruin F, Ter Horst S, van den Berg R, de Hooge M, van Gaalen F, Fagerli KM, Landewé R, van Oosterhout M, Bloem JL, van der Heijde D, Reijnierse M.

Skeletal Radiol. 2016 Mar;45(3):375-81. doi: 10.1007/s00256-015-2301-7. Epub 2015 Dec 4.

20.

Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?

Ramiro S, Landewé R, van der Heijde D, Harrison D, Collier D, Michaud K.

RMD Open. 2015 Nov 18;1(1):e000155. doi: 10.1136/rmdopen-2015-000155. eCollection 2015.

Supplemental Content

Loading ...
Support Center